2012
DOI: 10.1097/maj.0b013e318234cc67
|View full text |Cite
|
Sign up to set email alerts
|

Atypical Hyperplasia on Core Biopsy: Is Further Surgery Needed?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
9
0
1

Year Published

2014
2014
2018
2018

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(12 citation statements)
references
References 22 publications
2
9
0
1
Order By: Relevance
“…Our overall ADH upgrade rate was 12.9%, consistent with multiple prior studies, which have reported upgrade rates varying in the range of 11-62% [3,[16][17][18][19][20][21]. Previously reported upgrade rates are based on a mixture of cases diagnosed by both filmscreen mammography and digital mammography, either by report or referred on the basis of the dates of the studies.…”
Section: Discussionsupporting
confidence: 87%
See 1 more Smart Citation
“…Our overall ADH upgrade rate was 12.9%, consistent with multiple prior studies, which have reported upgrade rates varying in the range of 11-62% [3,[16][17][18][19][20][21]. Previously reported upgrade rates are based on a mixture of cases diagnosed by both filmscreen mammography and digital mammography, either by report or referred on the basis of the dates of the studies.…”
Section: Discussionsupporting
confidence: 87%
“…However, not all of these patients underwent surgical excision. In 2012, Polat et al [21] reported an upgrade rate of 11.3% for patients diagnosed with atypia from January 2007 through December 2008. On the basis of the date of this study, imaging may have been performed using digital mammography, although this was not reported [21].…”
Section: Discussionmentioning
confidence: 98%
“…To our knowledge, this is the first study to show statistically significant correlation with upstaging to malignancy for mixed ADH/ALH diagnosed by MRI-guided biopsy. A study by Polat et al 16 reported a greater upstage rate for mixed ADH/ALH of 18% versus an upstage rate of 12% for ADH alone when analyzing samples from all core needle biopsies, including stereotactic, ultrasonography, and MRI guidance. Graesslin et al 17 showed an upstage rate of 28% for mixed ADH/ALH versus 18% for ADH alone in patients with breast biopsy with stereotactic guidance.…”
Section: Discussionmentioning
confidence: 97%
“…Ancak kor biyopsilerde ADH saptanan olgularda, eksizyonel biyopsiye gidilmesi bugün için kabul edilen bir yaklaşım-dır [29]. İğne biyopsilerinde tanı alan ADH olgularının en azından bir kısmının cerrahi biyopsiye gitmeden izlenebilirliği ile ilgili yakın tarihli araştırmalar mevcuttur [30][31][32]. Atipik duktal hiperplazi üç ya da daha az terminal duktal lobüler ünite sınırlı olduğunda ve mamografideki tüm kalsifikasyonlar çıkarıldığın-da, eksizyonda daha yüksek derecede lezyon saptama olasılığı çok düşüktür [33,34].…”
Section: Yüksek Risk Lezyonlarunclassified